financetom
Business
financetom
/
Business
/
India Morning Newsletter, December 31
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
India Morning Newsletter, December 31
Dec 30, 2024 7:26 PM

To access a PDF version of this newsletter, please click here

If you would like to receive this newsletter via email, please register at:

https://solutions.lseg.com/MNCIndia-Subscriptionpage

For an index of our newsletters click on

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
LiveOne Says Collaboration With Tesla Surpassed 350,000 Paid Subscribers
LiveOne Says Collaboration With Tesla Surpassed 350,000 Paid Subscribers
Dec 18, 2024
08:30 AM EST, 12/18/2024 (MT Newswires) -- LiveOne ( LVO ) said Wednesday its multiyear collaboration with Tesla (TSLA) reached 350,000 paid subscribers as of Dec. 15. ...
Oklo Agrees to Deploy 12 GW of Powerhouses for Switch
Oklo Agrees to Deploy 12 GW of Powerhouses for Switch
Dec 18, 2024
08:29 AM EST, 12/18/2024 (MT Newswires) -- Oklo ( OKLO ) said Wednesday it has signed a non-binding Master Power Agreement with Switch to develop, construct, and operate 12 gigawatts of Aurora powerhouse projects through 2044. The deal includes power purchase agreements to supply energy to Switch facilities across the US, Oklo ( OKLO ) said. ...
Corvus Pharma Says Data From Atopic Dermatitis Study Shows Favorable Safety Profile; Shares Fall Pre-Bell
Corvus Pharma Says Data From Atopic Dermatitis Study Shows Favorable Safety Profile; Shares Fall Pre-Bell
Dec 18, 2024
08:31 AM EST, 12/18/2024 (MT Newswires) -- Corvus Pharmaceuticals ( CRVS ) said Wednesday that interim results from a phase 1 trial of its experimental drug soquelitinib to treat patients with moderate to severe atopic dermatitis showed a favorable safety and efficacy profile. The company said that patients receiving soquelitinib showed a 55.9% reduction in the Eczema Area and Severity...
HBT Financial Board Approves up to $15 Million Share Buyback Plan
HBT Financial Board Approves up to $15 Million Share Buyback Plan
Dec 18, 2024
08:30 AM EST, 12/18/2024 (MT Newswires) -- HBT Financial ( HBT ) said Wednesday its board approved an up to $15 million share buyback plan, to take effect after its current plan expires Jan. 1. The new buyback plan will be in effect until Jan. 1, 2026, the company said. Shares of the company were down 1.6% in recent Wednesday...
Copyright 2023-2026 - www.financetom.com All Rights Reserved